Alternative therapies are mentioned often by participants in the workers compensation sector trying to manage injured workers' pain while shifting away from the industry's dependence on opioids — and acupuncture is the talk of the town.
More stories
Mitchell
Article
Is Your Collision Repair Facility Ready for Electric Vehicles?
Some automakers are staking their futures on electric vehicles (EVs). General Motors announced it will launch twenty new, completely electric vehicles by 2023. VW plans to build 22 million electric cars in ten years. Daimler plans to offer an electrified variant for every model in its portfolio.
Disability
Article
Secrets to a Successful Stay At Work Program
A good stay-at-work program can offer many benefits to employees and employers, but establishing a successful plan can sometimes be a challenge. To help make this process easier, I'm joined by experts Kevin Ufier and Linda Mastropaolo who will offer tips on how to develop a successful program.
Workers' Comp
Blog
Investigating the Top Therapeutic Classes
First Script saw a decrease in opioid utilization across our retail and mail-order programs in 2018. In 2017, opioids made up 29.7% of total prescriptions, dropping to 26.9% in 2018, and representing a 2.8% decrease in utilization year over year.
Disability
Article
Secrets to a Successful Stay At Work Program
A good stay-at-work program can offer many benefits to employees and employers, but establishing a successful plan can sometimes be a challenge. To help make this process easier, I'm joined by Genex experts Kevin Ufier and Linda Mastropaolo who will offer tips on how to develop a successful program.
Workers' Comp
Article
Opioids in 2019: Insights into New Regulations and Studies of the Epidemic
Momentum in battling the opioid crisis continues. As more states enact opioid prescribing limits, the federal government proposes new legislation, while new studies look at the impact of opioid laws and medical marijuana on lessening opioid abuse.
Workers' Comp
Article
How Naloxone Can Help Fight the Opioid Crisis
As the U.S. looks for ways to stem the opioid crisis, one major strategy that has emerged is the use of naloxone to counteract opioid overdoses. The FDA’s recent approval of the generic form of Narcan®, which is the first generic formulation for naloxone nasal spray, provides another avenue to reverse the impact of the opioid crisis.